Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Not all Forms of Muscle Hypertonia Worsen With Fatigue: A Pilot Study in Para Swimmers.
Puce L, Bragazzi NL, Currà A, Marinelli L, Mori L, Cotellessa F, Chamari K, Ponzano M, Samanipour MH, Nikolaidis PT, Biz C, Ruggieri P, Trompetto C. Puce L, et al. Among authors: ponzano m. Front Physiol. 2022 Jun 22;13:902663. doi: 10.3389/fphys.2022.902663. eCollection 2022. Front Physiol. 2022. PMID: 35812331 Free PMC article.
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis.
Abbadessa G, Ponzano M, Bile F, Miele G, Signori A, Cepparulo S, Sparaco M, Signoriello E, Maniscalco GT, Lanzillo R, Morra VB, Lus G, Sormani MP, Lavorgna L, Bonavita S. Abbadessa G, et al. Among authors: ponzano m. Mult Scler Relat Disord. 2023 Jul;75:104731. doi: 10.1016/j.msard.2023.104731. Epub 2023 Apr 28. Mult Scler Relat Disord. 2023. PMID: 37163840
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study.
Miele G, Abbadessa G, Cavalla P, Valentino P, Marfia GA, Landi D, Bosa C, Vercellino M, De Martino A, Ponzano M, Lavorgna L, Bonavita S. Miele G, et al. Among authors: ponzano m. Mult Scler Relat Disord. 2022 Dec;68:104395. doi: 10.1016/j.msard.2022.104395. Epub 2022 Nov 3. Mult Scler Relat Disord. 2022. PMID: 36544324
Impact of tDCS on persistent COVID-19 olfactory dysfunction: a double-blind sham-controlled study.
Vestito L, Mori L, Trompetto C, Bagnasco D, Canevari RF, Ponzano M, Subbrero D, Cecchella E, Barbara C, Clavario P, Bandini F. Vestito L, et al. Among authors: ponzano m. J Neurol Neurosurg Psychiatry. 2023 Jan;94(1):87-88. doi: 10.1136/jnnp-2022-329162. Epub 2022 May 23. J Neurol Neurosurg Psychiatry. 2023. PMID: 35606106 Clinical Trial. No abstract available.
What happens after fingolimod discontinuation? A multicentre real-life experience.
Landi D, Signori A, Cellerino M, Fenu G, Nicoletti CG, Ponzano M, Mancuso E, Fronza M, Ricchiuto ME, Boffa G, Inglese M, Marfia GA, Cocco E, Frau J. Landi D, et al. Among authors: ponzano m. J Neurol. 2022 Feb;269(2):796-804. doi: 10.1007/s00415-021-10658-8. Epub 2021 Jun 16. J Neurol. 2022. PMID: 34136943
Signs and symptoms of COVID-19 in patients with multiple sclerosis.
Schiavetti I, Carmisciano L, Ponzano M, Cordioli C, Cocco E, Marfia GA, Inglese M, Filippi M, Radaelli M, Bergamaschi R, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Scandellari C, Cavalla P, Pesci I, Confalonieri P, Perini P, Trojano M, Lanzillo R, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M, Sormani MP; MuSC-19 Study Group. Schiavetti I, et al. Among authors: ponzano m. Eur J Neurol. 2022 Dec;29(12):3728-3736. doi: 10.1111/ene.15554. Epub 2022 Sep 23. Eur J Neurol. 2022. PMID: 36086905 Free PMC article.
104 results